Feedback / Questions
Rezdiffra (resmetirom) - Madrigal Pharma
Rezdiffra: Launch in EU for MASH in H2 2025
(43rd Annual J.P. Morgan Healthcare Conference, Madrigal Pharmaceuticals)
Jan 24, 2025
Launch Europe
•
Metabolic Dysfunction-Associated Steatohepatitis
https://ir.madrigalpharma.com/static-files/ecff0bde-5305-42e8-bdcc-9bf8d8bfbc5f
Jan 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious